Michael York

Affiliations

  • Chief Business Officer at Metacrine Inc. (MTCR), 2023-01-27
  • Vp, Corporate Development at Phasebio Pharmaceuticals Inc (PHAS), 2021-05-24
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PHAS $3.88 1,500 $5,820.00 1,500 2018-12-11 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MTCR $0.41 107,054 $44,331.06 103,499 2023-01-26 Filing